Chicago, IL - Almost half of patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) who received enoxaparin (Lovenox, Sanofi-Aventis) were given doses that were either higher or lower than ...

Aug. 18, 2004 — The U.S. Food and Drug Administration (FDA) and Aventis Pharmaceuticals notified healthcare professionals in March of revisions to the precautions section of drug labeling for ...

The objective of our study was to determine the feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates, and to assess response to treatment. Nineteen premature and ...

Add Yahoo as a preferred source to see more of our stories on Google. Learn more about the benefits and risks of taking Lovenox during pregnancy. While most pregnancies progress smoothly and without ...

The FDA is recommending that healthcare professionals carefully time the spinal catheter placement and removal in patients taking anticoagulants (eg, enoxaparin), and delay dosing of anticoagulants ...

A total of 15 pregnant subjects on therapeutic doses of enoxaparin (1 mg/kg ±20% subcutaneously (s.c.) twice daily (b.i.d.)) were enrolled prospectively in this cross-sectional pilot project. Three ...

A new study published in the journal Obstetrics & Gynecology indicates that weight-based enoxaparin dosing is significantly more effective than body mass index (BMI) based dosing for venous ...

Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...

DUBLIN--(BUSINESS WIRE)--The "Lovenox - Drug Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. 'Lovenox Drug Insight, 2018' highlights the drug marketed details and ...

Bayer has reported positive Phase II results with its oral Factor Xa inhibitor BAY 59-7939 in the prevention of venous thromboembolism in patients undergoing hip replacement surgery, and selected a ...